Overcoming the Challenges of Antiviral Defenses in Viral Vector Manufacturing

Jean-Simon Diallo, CEO and Scientific Founder, and JonDavid De Jong, VP Scientific Operations discuss the challenges innate cellular defenses pose to the successful production of vaccines and advanced therapies and what Virica is doing to tackle this problem.